Empa

EMPA-KIDNEY: meta-analysis results

EMPA-KIDNEY results: Empagliflozin reduces kidney disease progression and cardiovascular deaths

EMPA-KIDNEY results November 2022

Empa: Materials and Technologies to Shape the Future

#Hazte EL #Examen de #Medicina #Preventiva #EMPA

Tag der offenen Tür an der Empa Dübendorf

EMPA | Novos Equipamentos de Infraestruturas

EMPA-KIDNEY

Empa - Materials and technologies for a sustainable future

¿Sabe qué es el examen EMPA?

Welcome at Empa St. Gallen!

QUÉ ES EL EMPA

Die Empa - Das Buch

Estudio EMPA-KIDNEY

ESC TV On the Road - #AHA22 - DCP and EMPA-KIDNEY trials

EHJ Today - The EMPA-REG OUTCOME Trial

Welcome at Empa in St.Gallen!

Исследование EMPA-REG OUTCOME (Эмпаглифлозин)

Welcome at the Empa Campus in Dübendorf!

Impact of EMPA-REG OUTCOME

Why EMPA-REG Results Make This a “Very Exciting Time” in Diabetes Care

ADA 2020: Findings from EMPA-REG OUTCOME trial — Dr Muthiah Vaduganathan